Richard A. Young, Director at Omega Therapeutics, Inc. (OMGA), sold 5,000 shares at $8.00 ($40K) on 2023-05-01, disclosed to the SEC on 2023-05-03.
Scheduled sale ($40k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| OMGA | SELL | 2023-06-05 | $40K | — | Filing → |
| OMGA | SELL | 2023-04-10 | $40K | — | Filing → |
| OMGA | SELL | 2023-03-20 | $80K | — | Filing → |